2026 Perinatal Grand Rounds

Beyond the Bundle: A Conversation on Postpartum Hemorrhage and QI

Postpartum hemorrhage remains one of the leading causes of severe maternal morbidity—but improving outcomes takes more than checking the boxes on a safety bundle.

This presentation explores how healthcare teams can apply the principles of the AIM Obstetric Hemorrhage Patient Safety Bundle to drive meaningful improvements in care, strengthen systems, and improve outcomes for birthing people experiencing hemorrhage.

Register to unlock the course, then click ‘Continue.’ Course materials are available at the bottom of this page.
Write your awesome label here.
Patrick Jones - Course author
Meet the instructors

Tori O'Daniel, MD, FACOG

Dr. Tori O’Daniel is a Board-Certified OB/GYN who has been practicing since 2010. She attended the Medical University of Ohio. She then completed a four-year OB/GYN residency in Asheville, NC at Mountain Area Health Education Center (MAHEC) and was elected Chief Resident her final year. Dr. O’Daniel is the Senior Medical Director for Laborie Medical Technologies.

Patrick Jones - Course author

Madeline Skelton, DNP, APRN, WHNP-BC

She completed pre-nursing requirements at the University of Missouri – Columbia and received a Bachelor of Science in Nursing from Barnes-Jewish Goldfarb School of Nursing. She has a Doctorate in Nursing Practice from the University of Missouri – St. Louis. Currently, she is the Perinatal Quality Liaison at Laborie Medical Technologies and supports health care teams in improving perinatal quality care.

Learning Outcomes

At the conclusion of this activity, participants will be able to:
  • Describe the prevalence and consequences of postpartum hemorrhage.
  • Describe the "Four Rs."
  • Describe how the Four Rs can be applied to postpartum hemorrhage.


Accreditation Statement

Continuing Medical Education

Continuing Medical Education credit is not available for this educational activity.

Planning Committee

No one in control of content has any relevant financial relationships with ineligible companies.*
*Ineligible companies are those whose primary business is producing, marketing, selling, reselling, or distributing health care products used by or on patients.

Course Information

This webinar was recorded on 18 June 2026.

The expiration date for this course is 18 June 2029.